Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Seffalair Spiromax“
Suchtreffer
Begriffe & Kennungen
Seffalair Spiromax
Eintrag öffnenSeffalair Spiromax · 4.1 Therapeutic indications · 1
Eintrag öffnenSeffalair Spiromax · 4.3 Contraindications · 1
Eintrag öffnenSeffalair Spiromax · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenSeffalair Spiromax · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenSeffalair Spiromax · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenSeffalair Spiromax · 4.5 · 6 Interactions with beta blockers
Eintrag öffnenSeffalair Spiromax · 4.5 · 7 risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic cortic
Eintrag öffnenSeffalair Spiromax · 4.5 · Beta adrenergic blockers may weaken or antagonise the effect of salmeterol. Both non-selective and selective β
Eintrag öffnenSeffalair Spiromax · 4.5 · Clinically significant effects were not seen on blood pressure, heart rate, blood glucose, and blood potassium
Eintrag öffnenSeffalair Spiromax · 4.5 · Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk
Eintrag öffnenSeffalair Spiromax · 4.5 · Concomitant administration of other sympathomimetic medicinal products (alone or as part of combination therap
Eintrag öffnenSeffalair Spiromax · 4.5 · Fluticasone propionate
Eintrag öffnenSeffalair Spiromax · 4.5 · Fluticasone propionate and salmeterol are both poor substrates of P-glycoprotein (P-gp). Fluticasone did not s
Eintrag öffnenSeffalair Spiromax · 4.5 · In a small study in healthy volunteers, the slightly less potent CYP3A inhibitor ketoconazole increased the ex
Eintrag öffnenSeffalair Spiromax · 4.5 · In an interaction study in healthy subjects with intranasal fluticasone propionate, ritonavir (a highly potent
Eintrag öffnenSeffalair Spiromax · 4.5 · Interaction with P-glycoprotein inhibitors
Eintrag öffnenSeffalair Spiromax · 4.5 · Moderate CYP3A4 inhibitors Co-administration of erythromycin (500 mg orally 3 times a day) and salmeterol (50
Eintrag öffnenSeffalair Spiromax · 4.5 · Potent CYP3A4 inhibitors Co-administration of ketoconazole (400 mg orally once daily) and salmeterol (50 micro
Eintrag öffnenSeffalair Spiromax · 4.5 · Salmeterol
Eintrag öffnen